Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting

ClinicalTrials.gov ID: NCT00642499

Public ClinicalTrials.gov record NCT00642499. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 4:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Parallel-Group, Pilot Study of Oral Dronabinol Versus Placebo in the Treatment or Prevention of Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to determine if dronabinol is effective in preventing or treating nausea caused by HAART (highly active anti-retroviral therapy) in HIV and AIDS patients

Study identification

NCT ID
NCT00642499
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Solvay Pharmaceuticals
Industry
Enrollment
103 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2003 (Type not available)
Primary completion
Apr 2005 (Actual)
Completion
Apr 2005 (Actual)
Last update posted
Apr 2, 2008

2003 – 2005

United States locations

U.S. sites
36
U.S. states
15
U.S. cities
30
Facility City State ZIP Site status
Site 911 Bakersfield California — —
Site 919 Fresno California — —
Site 924 Los Angeles California — —
Site 932 Los Angeles California — —
Site 926 Palm Springs California — —
Site 946 Pasadena California — —
Site 913 Tarzana California — —
Site 907 Altamonte Springs Florida — —
Site 948 Miami Florida — —
Site 951 Miami Florida — —
Site 953 Miami Florida — —
Site 959 Miami Florida — —
Site 954 North Palm Beach Florida — —
Site 957 Pensacola Florida — —
Site 923 Port Saint Lucie Florida — —
Site 929 Sarasota Florida — —
Site 952 Tallahassee Florida — —
Site 931 Tampa Florida — —
Site 908 Decatur Georgia — —
Site 905 Boise Idaho — —
Site 914 Chicago Illinois — —
Site 928 Louisville Kentucky — —
Site 955 Louisville Kentucky — —
Site 958 New Orleans Louisiana — —
Site 934 Boston Massachusetts — —
Site 915 Springfield Missouri — —
Site 956 Somers Point New Jersey — —
Site 921 Albany New York — —
Site 910 Cincinnati Ohio — —
Site 941 Philadelphia Pennsylvania — —
Site 925 Dallas Texas — —
Site 917 Fort Worth Texas — —
Site 906 Houston Texas — —
Site 942 Houston Texas — —
Site 909 Tacoma Washington — —
Site 927 Vancouver Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00642499, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 2, 2008 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00642499 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →